The Anti-malarial Drug Artesunate Blocks Wnt/ β-catenin Pathway and Inhibits Growth, Migration and Invasion of Uveal Melanoma Cells.
CONCLUSION: Artesunate may be a potential interest for the therapy of uveal melanoma.
PMID: 29692251 [PubMed - as supplied by publisher]
Source: Current Cancer Drug Targets - Category: Cancer & Oncology Authors: Zheng L, Pan J Tags: Curr Cancer Drug Targets Source Type: research
More News: Cancer | Cancer & Oncology | China Health | Eye Cancers | Malaria | Melanoma | Multidrug Resistance | Skin Cancer | Uveal Melanoma